Background: Aim: To identify patients’ profiles associated with the initiation of a 2DR vs. a 3DR regimen with an InSTI plus tenofovir alafenamide/emtricitabine in an ART-naive population
Are patients starting first-line ART with a 2-drug regimen (2DR) with dolutegravir/lamivudine different from those initiating 3-drug regimens (3DR) based on an integrase strand transfer inhibitor (InSTI), plus tenofovir alafenamide/emtricitabine?
G. F. PELLICANOMembro del Collaboration Group
2021-01-01
Abstract
Background: Aim: To identify patients’ profiles associated with the initiation of a 2DR vs. a 3DR regimen with an InSTI plus tenofovir alafenamide/emtricitabine in an ART-naive populationFile in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
